Third Rock Ventures III L.P. 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:15 pm Unchanged |
2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 2,132,867 3.600% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 2,132,867 4.400% |
-3,706,293 (-63.47%) |
Filing |
| 2021-02-16 4:17 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 5,839,160 16.500% |
5,839,160 (New Position) |
Filing |